Skip to main content
SpringerLink
Log in

Management Options for Bipolar Disorder in Children and Adolescents

  • Therapy In Practice
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

During recent years there has been a dramatic increase in the use of psychotropic medication for the treatment of bipolar disorder (BPD) in children. There is an emerging set of data to support this use.

Mood stabilizers, including lithium and valproic acid (valproate sodium), have generally formed the mainstay of treatment in children and adolescents with BPD. However, the atypical antipsychotics, such as risperidone, aripiprazole, and quetiapine may be more effective as first-line treatment options and in some ways easier to use than the traditional mood stabilizers. As in adults, mood stabilization is often difficult to achieve in pediatric patients with BPD, and combined treatment with mood stabilizers and atypical antipscyhotics is commonly used.

Data from controlled trials of psychotropic medications in children and adolescents with BPD are very limited, and hence, in the majority of cases physicians base their treatment decisions on data from case reports, case series, or open trials. More controlled studies of both monotherapy and polypharmacotherapy for BPD in children and adolescents are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 1996; 35(12): 1575–83

    Article  PubMed  CAS  Google Scholar 

  2. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebocontrolled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54(11): 1031–7

    Article  PubMed  CAS  Google Scholar 

  3. Kovacs M, Goldston D, Gatsonis C. Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation. J Am Acad Child Adolesc Psychiatry 1993; 32(1): 8–20

    Article  PubMed  CAS  Google Scholar 

  4. Lewinsohn PM, Clarke GN, Seeley JR, et al. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 1994; 33(6): 809–18

    Article  PubMed  CAS  Google Scholar 

  5. Garfinkel BD, Froese A, Hood J. Suicide attempts in children and adolescents. Am J Psychiatry 1982; 139(10): 1257–61

    PubMed  CAS  Google Scholar 

  6. Rao U, Weissman MM, Martin JA, et al. Childhood depression and risk of suicide: a preliminary report of a longitudinal study. J Am Acad Child Adolesc Psychiatry 1993; 32(1): 21–7

    Article  PubMed  CAS  Google Scholar 

  7. Shaffer D. Suicide in childhood and early adolescence. J Child Psychol Psychiatry 1974; 15(4): 275–91

    Article  PubMed  CAS  Google Scholar 

  8. Brent DA. Correlates of the medical lethality of suicide attempts in children and adolescents. J Am Acad Child Adolesc Psychiatry 1987; 26(1): 87–91

    Article  PubMed  CAS  Google Scholar 

  9. Weinberg WA, Rehmet A. Childhood affective disorder and school problems. In: Cantwell DP, Carlson GA, editors. Affective disorders in childhood and adolescence: an update. Jamaica (NY): Spectrum Publishing Inc., 1983: 109–28

    Chapter  Google Scholar 

  10. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997; 36(9): 1168–76

    Article  PubMed  CAS  Google Scholar 

  11. Akiskal HS, Downs J, Jordan P, et al. Affective disorders in referred children and younger siblings of manic-depressives: mode of onset and prospective course. Arch Gen Psychiatry 1985; 42(10): 996–1003

    Article  PubMed  CAS  Google Scholar 

  12. Weinberg WA, Rutman J, Sullivan L, et al. Depression in children referred to an educational diagnostic center: diagnosis and treatment. Preliminary report. J Pediatr 1973; 83(6): 1065–72

    Article  PubMed  CAS  Google Scholar 

  13. Puig-Antich J, Kaufman J, Ryan ND, et al. The psychosocial functioning and family environment of depressed adolescents. J Am Acad Child Adolesc Psychiatry 1993; 32(2): 244–53

    Article  PubMed  CAS  Google Scholar 

  14. Fleming JE, Offord DR. Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 1990; 29(4): 571–80

    Article  PubMed  CAS  Google Scholar 

  15. Kashani JH, Carlson GA. Seriously depressed preschoolers. Am J Psychiatry 1987; 144(3): 348–50

    PubMed  CAS  Google Scholar 

  16. Kolvin I, Barrett ML, Bhate SR, et al. The Newcastle Child Depression Project: 0 diagnosis and classification of depression. Br J Psychiatry Suppl 1991; (11): 9–21

    Google Scholar 

  17. Puig-Antich J, Lukens E, Davies M, et al. Psychosocial functioning in prepubertal major depressive disorders: II. Interpersonal relationships after sustained recovery from affective episode. Arch Gen Psychiatry 1985; 42(5): 511–7

    Article  PubMed  CAS  Google Scholar 

  18. Weller EB, Weller RA, Fristad MA. Bipolar disorder in children: misdiagnosis, underdiagnosis, and future directions. J Am Acad Child Adolesc Psychiatry 1995; 34(6): 709–14

    Article  PubMed  CAS  Google Scholar 

  19. Hirschfeld RMA. Practice guideline for the treatment of patients with bipolar disorder: American Psychiatric Association. Am J Psychiatry 1994; 151(12 Suppl.): 1–36

    Google Scholar 

  20. Kafantaris V. Treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1995; 34(6): 732–41

    Article  PubMed  CAS  Google Scholar 

  21. McClellan J, Werry J. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder: American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997; 36(10 Suppl.): 157S–76S

    PubMed  CAS  Google Scholar 

  22. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73(1–2): 123–31

    Article  PubMed  Google Scholar 

  23. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995; 34(4): 454–63

    Article  PubMed  CAS  Google Scholar 

  24. Krasa NR, Tolbert HA. Adolescent bipolar disorder: a nine-year experience. J Affect Disord 1994; 30(3): 175–84

    Article  PubMed  CAS  Google Scholar 

  25. Geller B, Williams M, Zimerman B, et al. Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect Disord 1998; 51(2): 81–91

    Article  PubMed  CAS  Google Scholar 

  26. Burke KC, Burke JD, Regier DA, et al. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry 1990; 47(6): 511–8

    Article  PubMed  CAS  Google Scholar 

  27. Joyce PR. Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychol Med 1984; 14(1): 145–9

    Article  PubMed  CAS  Google Scholar 

  28. Lish JD, Dime-Meenan S, Whybrow PC, et al. The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31(4): 281–94

    Article  PubMed  CAS  Google Scholar 

  29. Goodwin F, Jamison K. Manic-depressive illness. New York: Oxford University Press, 1990

    Google Scholar 

  30. Loranger AW, Levine PM. Age at onset of bipolar affective illness. Arch Gen Psychiatry 1978; 35(11): 1345–8

    Article  PubMed  CAS  Google Scholar 

  31. LaGrone DM. Manic-depressive illness in early childhood: the case of Christopher. South Med J 1981; 74(4): 479–81

    Article  PubMed  CAS  Google Scholar 

  32. Varanka TM, Weller RA, Weller EB, et al. Lithium treatment of manic episodes with psychotic features in prepubertal children. Am J Psychiatry 1988; 145(12): 1557–9

    PubMed  CAS  Google Scholar 

  33. Welner Z, Reich W, Herjanic B, et al. Reliability, validity, and parent-child agreement studies of the Diagnostic Interview for Children and Adolescents (DICA). J Am Acad Child Adolesc Psychiatry 1987; 26(5): 649–53

    Article  PubMed  CAS  Google Scholar 

  34. Reich W. Diagnostic Interview for Children and Adolescents (DICA). J Am Acad Child Adolesc Psychiatry 2000; 39(1): 59–66

    Article  PubMed  CAS  Google Scholar 

  35. Costello A, Edelbrook C, Kalas R, et al. The NIMH Diagnostic Interview Schedule for Children (DISC). Pittsburgh (PA): Pergammon Press, 1982

    Google Scholar 

  36. Shaffer D, Fisher P, Lucas CP, et al. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 2000; 39(1): 28–38

    Article  PubMed  CAS  Google Scholar 

  37. Weller E, Weller R, Fristad M, et al. Children’s Interview for Psychiatric Syndromes (ChIPS). Washington (DC): American Psychiatric Press, 1999

    Google Scholar 

  38. Puig-Antich J, Chambers W. The schedule for affective disorders and schizophrenia for school-age children (Kiddie-SADS). New York: New York State Psychiatric Institute, 1978

    Google Scholar 

  39. Geller B, Warner K, Williams M, et al. Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord 1998; 51(2): 93–100

    Article  PubMed  CAS  Google Scholar 

  40. Kovacs M. The Children’s Depression, Inventory (CDI). Psychopharmacol Bull 1985; 21(4): 995–8

    PubMed  CAS  Google Scholar 

  41. Kovacs M. The interview schedule for children. Psychopharmacol Bull 1978; 21: 991–4

    Google Scholar 

  42. Hodges KK, Kline J, Stern L. The development of a child assessment interview for research and clinical use. J Abnorm Psychol 1982; 10: 173–89

    Article  CAS  Google Scholar 

  43. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–35

    Article  PubMed  CAS  Google Scholar 

  44. Fristad MA, Weller RA, Weller EB. The Mania Rating Scale (MRS): further reliability and validity studies with children. Ann Clin Psychiatry 1995; 7(3): 127–32

    Article  PubMed  CAS  Google Scholar 

  45. Fristad MA, Weller EB, Weller RA. The Mania Rating Scale: can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 1992; 31: 252–7

    Article  PubMed  CAS  Google Scholar 

  46. Biederman J, Wozniak J, Kiely K, et al. CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD. J Am Acad Child Adolesc Psychiatry 1995; 34(4): 464–71

    Article  PubMed  CAS  Google Scholar 

  47. Biederman J, Faraone S, Mick E, et al. Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 1996; 35(8): 997–1008

    Article  PubMed  CAS  Google Scholar 

  48. Geller B, Sun K, Zimerman B, et al. Complex and rapid-cycling in bipolar children and adolescents: a preliminary study. J Affect Disord 1995; 34(4): 259–68

    Article  PubMed  CAS  Google Scholar 

  49. West SA, McElroy SL, Strakowski SM, et al. Attention deficit hyperactivity disorder in adolescent mania. Am J Psychiatry 1995; 152(2): 271–3

    PubMed  CAS  Google Scholar 

  50. Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995; 34(7): 867–76

    Article  PubMed  CAS  Google Scholar 

  51. Carlson GA. Classification issues of bipolar disorders in childhood. Psychiatr Dev 1984; 2(4): 273–85

    PubMed  CAS  Google Scholar 

  52. Geller B, Zimerman B, Williams M, et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacol 2002; 12(1): 11–25

    Article  PubMed  Google Scholar 

  53. Kovacs M, Pollock M. Bipolar disorder and comorbid conduct disorder in childhood and adolescence. J Am Acad Child Adolesc Psychiatry 1995; 34(6): 715–23

    Article  PubMed  CAS  Google Scholar 

  54. Kutcher SP, Marton P, Korenblum M. Relationship between psychiatric illness and conduct disorder in adolescents. Can J Psychiatry 1989; 34(6): 526–9

    PubMed  CAS  Google Scholar 

  55. Carlson GA. Bipolar affective disorders in childhood and adolescence. In: Cantwell DP, Carlson GA, editors. Affective disorders in childhood and adolescence. New York: Spectrum Publishing Inc., 1983: 61–83

    Chapter  Google Scholar 

  56. Davis RE. Manic-depressive variant syndrome of childhood: a preliminary report. Am J Psychiatry 1979; 136(5): 702–6

    PubMed  CAS  Google Scholar 

  57. Carlson GA, Fennig S, Bromet EJ. The confusion between bipolar disorder and schizophrenia in youth: where does it stand in the 1990s? J Am Acad Child Adolesc Psychiatry 1994; 33(4): 453–60

    Article  PubMed  CAS  Google Scholar 

  58. Horowitz HA. The use of lithium in the treatment of the drug-induced psychotic reaction. Dis Nerv Syst 1975; 36(4): 159–63

    PubMed  CAS  Google Scholar 

  59. Ferro T, Carlson GA, Grayson P, et al. Depressive disorders: distinctions in children. J Am Acad Child Adolesc Psychiatry 1994; 33(5): 664–70

    Article  PubMed  CAS  Google Scholar 

  60. Weller RA, Weller EB, Tucker SG, et al. Mania in prepubertal children: has it been underdiagnosed? J Affect Disord 1986; 11(2): 151–4

    Article  PubMed  CAS  Google Scholar 

  61. Strober M, Morrell W, Burroughs J, et al. A family study of bipolar I disorder in adolescence: early onset of symptoms linked to increased familial loading and lithium resistance. J Affect Disord 1988; 15(3): 255–68

    Article  PubMed  CAS  Google Scholar 

  62. Akiskal HS, Weller EB. Mood disorders and suicide in children and adolescents. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. 5th ed. Baltimore (MD): Williams & Wilkins, 1989: 1981–94

    Google Scholar 

  63. Horowitz HA. Lithium and the treatment of adolescent manic depressive illness. Dis Nerv Syst 1977; 38(6): 480–3

    PubMed  CAS  Google Scholar 

  64. Lewinsohn PM, Rohde P, Seeley JR. Adolescent psychopathology: III. The clinical consequences of comorbidity. J Am Acad Child Adolesc Psychiatry 1995; 34(4): 510–9

    Article  PubMed  CAS  Google Scholar 

  65. Merikangas KR, Angst J, Eaton W, et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry Suppl 1996; (30): 58–67

    Google Scholar 

  66. Botteron KN, Vannier MW, Geller B, et al. Preliminary study of magnetic resonance imaging characteristics in 8- to 16-year-olds with mania. J Am Acad Child Adolesc Psychiatry 1995; 34(6): 742–9

    Article  PubMed  CAS  Google Scholar 

  67. Fetner HH, Geller B. Lithium and tricyclic antidepressants. Psychiatr Clin North Am 1992; 15(1): 223–4

    PubMed  CAS  Google Scholar 

  68. Youngerman J, Canino IA. Lithium carbonate use in children and adolescents: a survey of the literature. Arch Gen Psychiatry 1978; 35(2): 216–24

    Article  PubMed  CAS  Google Scholar 

  69. Weller EB, Danielyan AK, Weller RA. Somatic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin North Am 2002; 11(3): 595–617

    Article  Google Scholar 

  70. DeLong GR, Aldershof AL. Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis. J Am Acad Child Adolesc Psychiatry 1987; 26(3): 389–94

    Article  PubMed  CAS  Google Scholar 

  71. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000; 39(6): 713–20

    Article  PubMed  CAS  Google Scholar 

  72. Kowatch RA, DelBello MP. The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders. CNS Spectr 2003; 8(4): 273–80

    PubMed  Google Scholar 

  73. Findling RL, McNamara NK, Youngstrom EA, et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005; 44(5): 409–17

    Article  PubMed  Google Scholar 

  74. Geller B, Craney JL, Bolhofner K, et al. One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2001; 158(2): 303–5

    Article  PubMed  CAS  Google Scholar 

  75. Biederman J, Mick E, Bostic JQ, et al. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. J Clin Psychiatry 1998; 59(11): 628–37

    Article  PubMed  CAS  Google Scholar 

  76. Jairam R, Srinath S, Girimaji SC, et al. A prospective 4–5 year follow-up of juvenile onset bipolar disorder. Bipolar Disord 2004; 6(5): 386–94

    Article  PubMed  Google Scholar 

  77. Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36(4): 349–52

    Google Scholar 

  78. Alessi N, Naylor MW, Ghaziuddin M, et al. Update on lithium carbonate therapy in children and adolescents. J Am Acad Child Adolesc Psychiatry 1994; 33(3): 291–304

    Article  PubMed  CAS  Google Scholar 

  79. Belmaker RH, Bersudsky Y, Agam G, et al. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu Rev Med 1996; 47: 47–56

    Article  PubMed  CAS  Google Scholar 

  80. Manji HK, Chen G. PKC, MAP kinases and the bcl-2 family of proteins as longterm targets for mood stabilizers. Mol Psychiatry 2002; 7Suppl. 1: S46–56

    Article  PubMed  CAS  Google Scholar 

  81. Hashimoto R, Takei N, Shimazu K, et al. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 2002; 43(7): 1173–9

    Article  PubMed  CAS  Google Scholar 

  82. Vitiello B, Behar D, Malone R, et al. Pharmacokinetics of lithium carbonate in children. J Clin Psychopharmacol 1988; 8(5): 355–9

    Article  PubMed  CAS  Google Scholar 

  83. Schou M. Lithium in psychiatric therapy and prophylaxis. J Psychiatr Res 1968; 6(1): 67–95

    Article  PubMed  CAS  Google Scholar 

  84. Strober M, Morrell W, Lampert C, et al. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 1990; 147(4): 457–61

    PubMed  CAS  Google Scholar 

  85. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania: the Depakote Mania Study Group. JAMA 1994; 271(12): 918–24

    Article  PubMed  CAS  Google Scholar 

  86. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986; 22(3): 613–20

    PubMed  CAS  Google Scholar 

  87. Hsu LK. Lithium-resistant adolescent mania. J Am Acad Child Psychiatry 1986; 25(2): 280–3

    Article  PubMed  CAS  Google Scholar 

  88. Keller MB, Lavori PW, Coryell W, et al. Bipolar I: a five-year prospective followup. J Nerv Ment Dis 1993; 181(4): 238–45

    Article  PubMed  CAS  Google Scholar 

  89. Masi G, Mucci M, Millepiedi S. Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol 2002; 12(2): 93–9

    Article  PubMed  Google Scholar 

  90. McElroy SL, Keck Jr PE, Pope Jr HG, et al. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 1992; 12(1 Suppl.): 42S–52S

    Article  PubMed  CAS  Google Scholar 

  91. Pope HG. McElroy SL, Keck PE, et al. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991; 48(1): 62–8

    Article  PubMed  Google Scholar 

  92. Strober M. The naturalistic prospective course of juvenile bipolar illness. Second International Conference on Bipolar Disorder; 1997 Jun 19–21; Pittsburgh (PA)

  93. Hagino OR, Weller EB, Weller RA, et al. Untoward effects of lithium treatment in children aged four through six years. J Am Acad Child Adolesc Psychiatry 1995; 34(12): 1584–90

    Article  PubMed  CAS  Google Scholar 

  94. McKnew DH, Cytryn L, Buchsbaum MS, et al. Lithium in children of lithiumresponding parents. Psychiatry Res 1981; 4(2): 171–80

    Article  PubMed  CAS  Google Scholar 

  95. DeLong GR, Nieman GW. Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness. Psychopharmacol Bull 1983; 19(2): 258–65

    PubMed  CAS  Google Scholar 

  96. Carlson GA, Rapport MD, Pataki CS, et al. Lithium in hospitalized children at 4 and 8 weeks: mood, behavior and cognitive effects. J Child Psychol Psychiatry 1992; 33(2): 411–25

    Article  PubMed  CAS  Google Scholar 

  97. Gram LF, Overo KF, Andersen J, et al. Lu 5–003 in antidepressive therapy: a controlled clinical trial with simultaneous measurement of pharmacokinetic parameters [letter]. Nord Psykiatr Tidsskr 1972; 26(6): 361

    Article  PubMed  CAS  Google Scholar 

  98. Brumback RA, Weinberg WA. Mania in childhood: II. Therapeutic trial of lithium carbonate and further description of manic-depressive illness in children. Am J Dis Child 1977; 131(10): 1122–6

    PubMed  CAS  Google Scholar 

  99. Carlson G, Strober M. Manic-depressive illness in early adolescence: a study of clinical and diagnostic characteristics in six cases. J Am Acad Child Adolesc Psychiatry 1978; 17(1): 138–53

    Article  CAS  Google Scholar 

  100. Hassanyeh F, Davison K. Bipolar affective psychosis with onset before age 16 years: report of 10 cases. Br J Psychiatry 1980; 137: 530–9

    Article  PubMed  CAS  Google Scholar 

  101. Campbell M, Adams PB, Small AM, et al. Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study [published erratum appears in J Am Acad Child Adolesc Psychiatry 1995 May; 34 (5): 694]. J Am Acad Child Adolesc Psychiatry 1995; 34(4): 445–53

    Article  PubMed  CAS  Google Scholar 

  102. Campbell M, Fish B, Korein J, et al. Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children. J Autism Child Schizophr 1972; 2(3): 234–63

    Article  PubMed  CAS  Google Scholar 

  103. Campbell M, Small AM, Green WH, et al. Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 1984; 41(7): 650–6

    Article  PubMed  CAS  Google Scholar 

  104. Siassi I. Lithium treatment of impulsive behavior in children. J Clin Psychiatry 1982; 43(12): 482–4

    PubMed  CAS  Google Scholar 

  105. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998; 37(2): 171–8

    Article  PubMed  CAS  Google Scholar 

  106. Cohn CK. Lithium. Tex Med 1977; 73(10): 73–5

    PubMed  CAS  Google Scholar 

  107. Joshi P, Capozzoli JA, Coyle JT. Effective management with lithium of a persistent, post-traumatic hypomania in a 10-year-old child. J Dev Behav Pediatr 1985; 6(6): 352–4

    Article  PubMed  CAS  Google Scholar 

  108. Geller B, Fox LW, Fletcher M. Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds. J Am Acad Child Adolesc Psychiatry 1993; 32(1): 43–50

    Article  PubMed  CAS  Google Scholar 

  109. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria for a selected group of functional disorders. 3rd ed. New York: New York State Psychiatric Institute, 1978

    Google Scholar 

  110. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998; 37(2): 171–8

    Article  PubMed  CAS  Google Scholar 

  111. Weller EB, Weller RA, Fristad MA. Lithium dosage guide for prepubertal children: a preliminary report. J Am Acad Child Psychiatry 1986; 25(1): 92–5

    Article  PubMed  CAS  Google Scholar 

  112. Physician’s desk reference (PDR). 54th ed. Oradell (NJ): Medical Economics, 2000

  113. Geller B, Fetner HH. Children’s 24-hour serum lithium level after a single dose predicts initial dose and steady-state plasma level [letter]. J Clin Psychopharmacol 1989; 9(2): 155

    Article  PubMed  CAS  Google Scholar 

  114. Hagino OR, Weller EB, Weller RA, et al. Comparison of lithium dosage methods for preschool- and early school-age children. J Am Acad Child Adolesc Psychiatry 1998; 37(1): 60–5

    Article  PubMed  CAS  Google Scholar 

  115. Moore CM, Demopulos CM, Henry ME, et al. Brain-to-serum lithium ratio and age: an in vivo magnetic resonance spectroscopy study. Am J Psychiatry 2002; 159(7): 1240–2

    Article  PubMed  Google Scholar 

  116. Bendz H, Sjodin I, Toss G, et al. Hyperparathyroidism and long-term lithium therapy: a cross-sectional study and the effect of lithium withdrawal. J Intern Med 1996; 240(6): 357–65

    Article  PubMed  CAS  Google Scholar 

  117. Calabrese JR, Fatemi SH, Kujawa M, et al. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996; 16 (2 Suppl. 1): 24S–31S

    Article  PubMed  CAS  Google Scholar 

  118. Bowden CL. Predictors of response to divalproex and lithium. J Clin Psychiatry 1995; 56Suppl. 3: 25–30

    PubMed  Google Scholar 

  119. Faedda GL, Baldessarini RJ, Tohen M, et al. Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry 1991; 148(9): 1237–9

    PubMed  CAS  Google Scholar 

  120. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321(22): 1489–93

    Article  PubMed  CAS  Google Scholar 

  121. Post RM, Rubinow DR, Uhde TW, et al. Dysphoric mania: clinical and biological correlates. Arch Gen Psychiatry 1989; 46(4): 353–8

    Article  PubMed  CAS  Google Scholar 

  122. Grof P, Duffy A, Cavazzoni P, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry 2002; 63(10): 942–7

    Article  PubMed  CAS  Google Scholar 

  123. Faedda GL, Tondo L, Baldessarini RJ, et al. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar mood disorders. Arch Gen Psychiatry 1993; 50(6): 448–55

    Article  PubMed  CAS  Google Scholar 

  124. Strober M, Schmidt-Lackner S, Freeman R, et al. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34(6): 724–31

    Article  PubMed  CAS  Google Scholar 

  125. Ahrens B, Grof P, Moller HJ, et al. Extended survival of patients on long-term lithium treatment. Can J Psychiatry 1995; 40(5): 241–6

    PubMed  CAS  Google Scholar 

  126. Muller-Oerlinghausen B, Wolf T, Ahrens B, et al. Mortality during initial and during later lithium treatment: a collaborative study by the International Group for the Study of Lithium-Treated Patients. Acta Psychiatr Scand 1994; 90(4): 295–7

    Article  PubMed  CAS  Google Scholar 

  127. Muller-Oerlinghausen B, Ahrens B, Grof E, et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992; 86(3): 218–22

    Article  PubMed  CAS  Google Scholar 

  128. Schou M, Hansen HE, Thomsen K, et al. Lithium treatment in Aarhus: 2. Risk of renal failure and of intoxication. Pharmacopsychiatry 1989; 22(3): 101–3

    Article  PubMed  CAS  Google Scholar 

  129. Schou M. Prophylactic lithium treatment of unipolar and bipolar manic-depressive illness. Psychopathology 1995; 28Suppl. 1: 81–5

    Article  PubMed  Google Scholar 

  130. Kutcher SP, Marton P, Korenblum M. Adolescent bipolar illness and personality disorder. J Am Acad Child Adolesc Psychiatry 1990; 29(3): 355–8

    Article  PubMed  CAS  Google Scholar 

  131. Bendz H, Aurell M, Balldin J, et al. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994; 9(9): 1250–4

    PubMed  CAS  Google Scholar 

  132. Gelenberg AJ, Schoonover SC. Bipolar disorder. In: Bassuk EL, Schoonover SC, Gelenberg AJ, editors. The practitioner’s guide to psychoactive drugs. 3rd ed. New York: Plenum, 1991: 91–124

    Chapter  Google Scholar 

  133. Campbell M, Silva RR, Kafantaris V, et al. Predictors of side effects associated with lithium administration in children. Psychopharmacol Bull 1991; 27(3): 373–80

    PubMed  CAS  Google Scholar 

  134. Khandelwal SK, Varma VK, Srinivasa Murthy R. Renal function in children receiving long-term lithium prophylaxis. Am J Psychiatry 1984; 141(2): 278–9

    PubMed  CAS  Google Scholar 

  135. Sakarcan A, Thomas DB, O’Reilly KP, et al. Lithium-induced nephrotic syndrome in a young pediatric patient. Pediatr Nephrol 2002; 17(4): 290–2

    Article  PubMed  Google Scholar 

  136. Birch NJ, Horsman A, Hullin RP. Lithium, bone and body weight studies in longterm lithium-treated patients and in the rat. Neuropsychobiology 1982; 8(2): 86–92

    Article  PubMed  CAS  Google Scholar 

  137. Silva RR, Campbell M, Golden RR, et al. Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacol Bull 1992; 28(3): 319–26

    PubMed  CAS  Google Scholar 

  138. Moltedo JM, Porter GA, State MW, et al. Sinus node dysfunction associated with lithium therapy in a child. Tex Heart Inst J 2002; 29(3): 200–2

    PubMed  Google Scholar 

  139. Viesselman JO, Yaylayan S, Weller EB, et al. Antidysthymic drugs (antidepressants and antimanics). In: Werry JS, Aman MG, editors. Practitioner’s guide to psychoactive drugs for children and adolescents. New York: Plenum, 1993: 239–68

    Chapter  Google Scholar 

  140. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium [published erratum appears in JAMA 1994 May 18; 271 (19): 1485]. JAMA 1994; 271(2): 146–50

    Article  PubMed  CAS  Google Scholar 

  141. Chen G, Manji HK, Wright CB, et al. Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology 1996; 15(3): 271–80

    Article  PubMed  CAS  Google Scholar 

  142. Manji HK, Chen G, Hsiao JK, et al. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy. J Clin Psychiatry 1996; 57Suppl. 13: 34–46

    PubMed  CAS  Google Scholar 

  143. Cloyd JC, Fischer JH, Kriel RL, et al. Valproic acid pharmacokinetics in children: IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin Pharmacol Ther 1993; 53(1): 22–9

    Article  PubMed  CAS  Google Scholar 

  144. Kastner T, Friedman DL. Verapamil and valproic acid treatment of prolonged mania. J Am Acad Child Adolesc Psychiatry 1992; 31(2): 271–5

    Article  PubMed  CAS  Google Scholar 

  145. Kastner T, Friedman DL, Plummer AT, et al. Valproic acid for the treatment of children with mental retardation and mood symptomatology. Pediatrics 1990; 86(3): 467–72

    PubMed  CAS  Google Scholar 

  146. Whittier MC, West SA, Galli VB, et al. Valproic acid for dysphoric mania in a mentally retarded adolescent [letter]. J Clin Psychiatry 1995; 56(12): 590–1

    PubMed  CAS  Google Scholar 

  147. Papatheodorou G, Kutcher SP. Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacol Bull 1993; 29(2): 213–9

    PubMed  CAS  Google Scholar 

  148. Papatheodorou G, Kutcher SP, Katic M, et al. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol 1995; 15(2): 110–6

    Article  PubMed  CAS  Google Scholar 

  149. West SA, Keck PE, McElroy SL, et al. Open trial of valproic acid in the treatment of adolescent mania. J Child Adolesc Psychopharmacol 1994; 4(4): 263–7

    Article  Google Scholar 

  150. Donovan SJ, Susser ES, Nunes EV, et al. Divalproex treatment of disruptive adolescents: a report of 10 cases. J Clin Psychiatry 1997; 58(1): 12–5

    Article  PubMed  CAS  Google Scholar 

  151. Deltito JA, Levitan J, Damore J, et al. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients. Acta Psychiatr Scand 1998; 97(3): 236–40

    Article  PubMed  CAS  Google Scholar 

  152. Wagner KD, Weller EB, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002; 41(10): 1224–30

    Article  PubMed  Google Scholar 

  153. Pavuluri MN, Henry DB, Carbray JA, et al. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 2005; 7(3): 266–73

    Article  PubMed  CAS  Google Scholar 

  154. Bowden CL, Janicak PG, Orsulak P, et al. Relation of serum valproic acid concentration to response in mania. Am J Psychiatry 1996; 153(6): 765–70

    PubMed  CAS  Google Scholar 

  155. Pedley TA, Scheuer ML, Walczak TS. Epilepsy. In: Rowland LP, editor. Merrits textbook of neurology. 9th ed. Baltimore (MA): Williams & Wilkins, 1995: 845–69

    Google Scholar 

  156. Rosenberg DR, Holttum J, Gershon S. Textbook of pharmacotherapy for child and adolescent psychiatric disorders. New York: Brunner/Mazel, 1994

    Google Scholar 

  157. Bryant III AE, Dreifuss FE. Valproic acid hepatic fatalities: III. US experience since 1986. Neurology 1996; 46(2): 465–9

    Article  PubMed  Google Scholar 

  158. Silberstein SD, Wilmore LJ. Divalproex sodium: migraine treatment and monitoring. Headache 1996; 36(4): 239–42

    Article  PubMed  CAS  Google Scholar 

  159. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproic acid for epilepsy. N Engl J Med 1993; 329(19): 1383–8

    Article  PubMed  CAS  Google Scholar 

  160. Isojarvi JI, Laatikainen TJ, Knip M, et al. Obesity and endocrine disorders in women taking valproic acid for epilepsy. Ann Neurol 1996; 39(5): 579–84

    Article  PubMed  CAS  Google Scholar 

  161. Isojarvi JI, Rattya J, Myllyla VV, et al. Valproic acid, lamotrigine, and insulinmediated risks in women with epilepsy. Ann Neurol 1998; 43(4): 446–51

    Article  PubMed  CAS  Google Scholar 

  162. Ryan ND, Bhatara VS, Perel JM. Mood stabilizers in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38(5): 529–36

    Article  PubMed  CAS  Google Scholar 

  163. Pleak RR, Birmaher B, Gavrilescu A, et al. Mania and neuropsychiatric excitation following carbamazepine. J Am Acad Child Adolesc Psychiatry 1988; 27(4): 500–3

    Article  PubMed  CAS  Google Scholar 

  164. Okuma T, Kishimoto A, Inoue K, et al. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatr Neurol Jpn 1973; 27(4): 283–97

    PubMed  CAS  Google Scholar 

  165. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 1996; 128(2): 115–29

    Article  PubMed  CAS  Google Scholar 

  166. Stuppaeck C, Barnas C, Miller C, et al. Carbamazepine in the prophylaxis of mood disorders. J Clin Psychopharmacol 1990; 10(1): 39–42

    Article  PubMed  CAS  Google Scholar 

  167. Solomon DA, Keitner GI, Ryan CE, et al. Polypharmacy in bipolar I disorder. Psychopharmacol Bull 1996; 32(4): 579–87

    PubMed  CAS  Google Scholar 

  168. Cueva JE, Overall JE, Small AM, et al. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1996; 35(4): 480–90

    Article  PubMed  CAS  Google Scholar 

  169. Evans RW, Clay TH, Gualtieri CT. Carbamazepine in pediatric psychiatry. J Am Acad Child Adolesc Psychiatry 1987; 26(1): 2–8

    Article  PubMed  CAS  Google Scholar 

  170. Kafantaris V, Campbell M, Padron-Gayol MV, et al. Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study [published erratum appears in Psychopharmacol Bull 1992; 28 (3): 220]. Psychopharmacol Bull 1992; 28(2): 193–9

    PubMed  CAS  Google Scholar 

  171. Post RM, Uhde TW, Roy-Byrne PP, et al. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987; 21(1): 71–83

    Article  PubMed  CAS  Google Scholar 

  172. Bocchetta A, Chillotti C, Severino G, et al. Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectiveness. J Clin Psychopharmacol 1997; 17(2): 92–6

    Article  PubMed  CAS  Google Scholar 

  173. Woolston JL. Case study: carbamazepine treatment of juvenile-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 1999; 38(3): 335–8

    Article  PubMed  CAS  Google Scholar 

  174. Garfinkel M, Garfinkel L, Himmelhoch J, et al. Lithium carbonate and carbamazepine: an effective treatment for adolescent manic or mixed bipolar patients. Scientific Proceedings of the 32nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 1985 Oct 23–27; San Antonio (TX)

  175. Ballenger JC. The use of anticonvulsants in manic-depressive illness. J Clin Psychiatry 1988; 49 Suppl.: 21–5

    PubMed  Google Scholar 

  176. Teitelbaum M. Oxcarbazepine in bipolar disorder. J Am Acad Child Adolesc Psychiatry 2001; 40(9): 993–4

    Article  PubMed  CAS  Google Scholar 

  177. Fatemi SH, Rapport DJ, Calabrese JR, et al. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997; 58(12): 522–7

    Article  PubMed  CAS  Google Scholar 

  178. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder: Lamictal 614 Study Group. J Clin Psychiatry 2000; 61(11): 841–50

    Article  PubMed  CAS  Google Scholar 

  179. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20(6): 607–14

    Article  PubMed  CAS  Google Scholar 

  180. Chaffin JJ, Davis SM. Suspected lamotrigine-induced toxic epidermal necrolysis. Ann Pharmacother 1997; 31(6): 720–3

    PubMed  CAS  Google Scholar 

  181. Dooley J, Camfield P, Gordon K, et al. Lamotrigine-induced rash in children. Neurology 1996; 46(1): 240–2

    Article  PubMed  CAS  Google Scholar 

  182. Fogh K, Mai J. Toxic epidermal necrolysis after treatment with lamotrigine (Lamictal). Seizure 1997; 6(1): 63–5

    Article  PubMed  CAS  Google Scholar 

  183. Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cycling bipolar disorder. Am J Psychiatry 1997; 154(8): 1171–2

    PubMed  CAS  Google Scholar 

  184. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998; 49(3): 229–33

    Article  PubMed  CAS  Google Scholar 

  185. Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder [letter]. J Neuropsychiatry Clin Neuroscinces 1997; 9(2): 301

    CAS  Google Scholar 

  186. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997; 154(2): 291–2

    PubMed  CAS  Google Scholar 

  187. Young LT, Robb JC, Patelis-Siotis I, et al. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42(9): 851–3

    Article  PubMed  CAS  Google Scholar 

  188. Tallian KB, Nahata MC, Lo W, et al. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 1996; 37(5): 501–2

    Article  PubMed  CAS  Google Scholar 

  189. Lee DO, Steingard RJ, Cesena M, et al. Behavioral side effects of gabapentin in children. Epilepsia 1996; 37(1): 87–90

    Article  PubMed  CAS  Google Scholar 

  190. Pande AC, Crockatt JG, Janney CA, et al. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2 (3 Pt 2): 249–55

    Article  PubMed  CAS  Google Scholar 

  191. Soutullo CA, Casuto LS, Keck Jr PE. Gabapentin in the treatment of adolescent mania: a case report. J Child Adolesc Psychopharmacol 1998; 8(1): 81–5

    Article  PubMed  CAS  Google Scholar 

  192. DelBello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002; 41(10): 1216–23

    Article  PubMed  Google Scholar 

  193. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003; 160(2): 255–61

    Article  PubMed  Google Scholar 

  194. Glick ID, Murray SR, Vasudevan P, et al. Treatment with atypical antipsychotics: new indications and new populations. J Psychiatr Res 2001; 35(3): 187–91

    Article  PubMed  CAS  Google Scholar 

  195. Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 2001; 52: 503–17

    Article  PubMed  CAS  Google Scholar 

  196. Janicak PG, Newman RH, Davis JM. Advances in the treatment of mania and related disorders. Psychiatric Annals 1992; 22: 92–103

    Google Scholar 

  197. Kafantaris V, Coletti DJ, Dicker R, et al. Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J Am Acad Child Adolesc Psychiatry 2001; 40(12): 1448–56

    Article  PubMed  CAS  Google Scholar 

  198. Gupta S, Masand P. Olanzapine: review of its pharmacology and indications in clinical practice. Prymary Psychiatry 1997; 53: 73–82

    Google Scholar 

  199. Keck PJ, McElroy S, Arnold L. Bipolar disorder. Med Clin North Am 2001; 85: 645–61

    Article  PubMed  Google Scholar 

  200. Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14(6): 339–43

    Article  PubMed  CAS  Google Scholar 

  201. Tohen M, Sanger T, McElroy S, et al. Olanzapine versus placebo in the treatment of acute mania: Olanzapine HGEH Study Group. Am J Psychiatry 1999 May; 156(5): 702–9

    PubMed  CAS  Google Scholar 

  202. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000; 57(9): 841–9

    Article  PubMed  CAS  Google Scholar 

  203. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21(3): 176–80

    PubMed  CAS  Google Scholar 

  204. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159(7): 1146–54

    Article  PubMed  Google Scholar 

  205. Keck Jr PE, Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003; 160(4): 741–8

    Article  PubMed  Google Scholar 

  206. Keck Jr PE, Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003 Sep; 160(9): 1651–8

    Article  PubMed  Google Scholar 

  207. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153(6): 759–64

    PubMed  CAS  Google Scholar 

  208. Kowatch RA, Suppes T, Gilfillan SK, et al. Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: a clinical case series. J Child Adolesc Psychopharmacol 1995; 5: 241–53

    Article  Google Scholar 

  209. Killian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354(9193): 1841–5

    Article  Google Scholar 

  210. Arvanitis LA, Miller BG. Multiple fixed doses of ‘Seroquel’ (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 1997; 42(4): 233–46

    Article  PubMed  CAS  Google Scholar 

  211. Copolov DL, Link CG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophrenia. Psychol Med 2000; 30(1): 95–105

    Article  PubMed  CAS  Google Scholar 

  212. Peuskens J, Link CG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997; 96(4): 265–73

    Article  PubMed  CAS  Google Scholar 

  213. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 1997; 54(6): 549–57

    Article  PubMed  CAS  Google Scholar 

  214. McConville BJ, Arvantis LA, Thyrum PT, et al. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 2000; 61(4): 252–60

    Article  PubMed  CAS  Google Scholar 

  215. McConville B, Carrero L, Sweitzer D, et al. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol 2003; 13(1): 75–82

    Article  PubMed  Google Scholar 

  216. Vieta E, Gasto C, Colom F, et al. Treatment of refractory rapid cycling bipolar disorder with risperidone [letter]. J Clin Psychopharmacol 1998; 18(2): 172–4

    Article  PubMed  CAS  Google Scholar 

  217. Ghaemi SN, Sachs GS, Baldassano CF, et al. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry 1997; 42(2): 196–9

    PubMed  CAS  Google Scholar 

  218. Goodnick PJ. Risperidone treatment of refractory acute mania [letter]. J Clin Psychiatry 1995; 56(9): 431–2

    PubMed  CAS  Google Scholar 

  219. McIntyre R, Young LT, Hasey G, et al. Risperidone treatment of bipolar disorder [letter]. Can J Psychiatry 1997; 42(1): 88–90

    PubMed  CAS  Google Scholar 

  220. Tohen M, Zarate Jr CA, Centorrino F, et al. Risperidone in the treatment of mania. J Clin Psychiatry 1996; 57(6): 249–53

    PubMed  CAS  Google Scholar 

  221. Frazier JA, Meyer MC, Biederman J, et al. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999; 38(8): 960–5

    Article  PubMed  CAS  Google Scholar 

  222. Biederman J, Mick E, Wozniak J, et al. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Clin Adolesc Psychiatry 2005; 15(2): 311–7

    Google Scholar 

  223. Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 2002; 346(1): 16–22

    Article  PubMed  CAS  Google Scholar 

  224. Kumra S, Herion D, Jacobsen LK, et al. Case study: risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 1997; 36(5): 701–5

    Article  PubMed  CAS  Google Scholar 

  225. Tohen M, Sanger T, Tollefson GD, et al. Olanzapine versus haloperidol in the treatment of schizoaffective bipolar patients. Second International Conference on Bipolar Disorder; 1997 Jun 19–21; Pittsburgh (PA)

  226. Tollefson GD, Beasley Jr CM, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997; 154(4): 457–65

    PubMed  CAS  Google Scholar 

  227. McElroy SL, Frye M, Denicoff K, et al. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord 1998; 49(2): 119–22

    Article  PubMed  CAS  Google Scholar 

  228. Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003; 160(7): 1263–71

    Article  PubMed  Google Scholar 

  229. Soutullo CA, Sorter MT, Foster KD, et al. Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 1999; 53(3): 279–83

    Article  PubMed  CAS  Google Scholar 

  230. Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11(3): 239–50

    Article  PubMed  CAS  Google Scholar 

  231. Chang KD, Ketter TA. Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psychopharmacol 2000; 10(1): 45–9

    Article  PubMed  CAS  Google Scholar 

  232. Krishnamoorthy J, King BH. Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 1998; 8(2): 107–13

    Article  PubMed  CAS  Google Scholar 

  233. Biederman J, McDonnell MA, Wozniak J, et al. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr 2005; 10(2): 141–8

    PubMed  Google Scholar 

  234. Barzman DH, DelBello MP, Kowatch RA, et al. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J Child Adolesc Psychopharmacol 2004; 14(4): 593–600

    Article  PubMed  Google Scholar 

  235. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproic acid or lithium in the treatment of mania in patients partially nonresponsive to valproic acid or lithium monotherapy. Arch Gen Psychiatry 2002; 59(1): 62–9

    Article  PubMed  CAS  Google Scholar 

  236. Kowatch RA, Sethuraman G, Hume JH, et al. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003; 53(11): 978–84

    Article  PubMed  CAS  Google Scholar 

  237. Pavuluri MN, Henry DB, Carbray JA, et al. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 2004; 82Suppl. 1: S103–11

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Dr R.A. Kowatch has received research support from Bristol-Myers Squibb, Stanley Research Foundation, and the National Institute of Mental Health. He is on the consultant/advisory board for Eli Lilly, GlaxoSmithKline, Janssen, Otsuka, and Creative Educational Concepts; and on the Speaker’s Bureau for Astra-Zeneca and Abbott.

Author information

Authors and Affiliations

  1. Department of Psychiatry, Cincinnati Children’s Hospital Medical Center and The University of Cincinnati Medical Center, PO Box 670559, Cincinnati, MSB 7261, Ohio, 45267-0559, USA

    Arman Danielyan &  Robert A. Kowatch

  2. The University of Cincinnati Medical Center, Cincinnati, Ohio, USA

    Robert A. Kowatch

Authors
  1. Arman Danielyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. Kowatch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert A. Kowatch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danielyan, A., Kowatch, R.A. Management Options for Bipolar Disorder in Children and Adolescents. Pediatr-Drugs 7, 277–294 (2005). https://doi.org/10.2165/00148581-200507050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200507050-00002

Keywords

Search

Navigation